% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@INBOOK{AdelajaOsibote:276102,
author = {Vahidfar, Nasim and Bakhshi Kashi, Mohsen and Afshar, Saeed
and Sheikhzadeh, Peyman and Farzanefar, Saeed and Salehi,
Yalda and Delpasand, Ebrahim and Molloy, Eóin N. and
Mirzaei, Siroos and Ahmadzadehfar, Hojjat and Eppard,
Elisabeth},
editor = {Adelaja Osibote, Otolorin and Eppard, Elisabeth},
title = {{R}ecent {A}dvances of {C}opper-64 {B}ased
{R}adiopharmaceuticals in {N}uclear {M}edicine},
publisher = {IntechOpen},
reportid = {DZNE-2025-00183},
pages = {1 - 24},
year = {2024},
comment = {Advances in Dosimetry and New Trends in
Radiopharmaceuticals / Adelaja Osibote, Otolorin (Editor) ;
: IntechOpen, , Chapter 5 ; ISBN: 978-0-85466-008-7 ;
doi:10.5772/intechopen.110965},
booktitle = {Advances in Dosimetry and New Trends
in Radiopharmaceuticals / Adelaja
Osibote, Otolorin (Editor) ; :
IntechOpen, , Chapter 5 ; ISBN:
978-0-85466-008-7 ;
doi:10.5772/intechopen.110965},
abstract = {Copper radioisotopes including copper-60/61/62, and -64
exhibit a wide range of decay characteristics, making them
appropriate choices for diagnostic/therapeutic (theranostic)
applications in nuclear medicine. One notable feature of
copper is the feasible coordination chemistry, which makes
radiolabeling of a wide range of chemical structures
including antibodies, proteins, peptides, and other
biologically relevant small molecules possible. This chapter
will summarize common radiopharmaceuticals of copper-64 and
their radiation dosimetry in order to highlight recent
improvements of positron emission tomography diagnostics.},
cin = {AG Maaß},
cid = {I:(DE-2719)1311001},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)7},
doi = {10.5772/intechopen.1003993},
url = {https://pub.dzne.de/record/276102},
}